Physician profile
Paul E Creger
NPI 1861121386
$7,616.22
in general payments reported to CMS, 2019-2025
15 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $161 · 2023: $510 · 2024: $6,312 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,821 · Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,820.75 |
| Food and Beverage | $1,634.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,954.44 | 2024-2025 | |
| Prytime Medical Devices, INC. | $240.96 | 2023 | Er-Reboa Plus |
| Integra Lifesciences Corporation | $233.52 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $228.85 | 2025 | Phasix Mesh |
| Medtronic, INC. | $195.84 | 2023-2024 | Ellipsys Vascular Access System, Endurant Iis |
| Polynovo North America LLC | $164.38 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $148.95 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Zimmer Biomet Holdings, INC. | $145.35 | 2022 | |
| Silk Road Medical, INC. | $131.60 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Baxter Healthcare | $84.13 | 2024 | Coseal, Preveleak |
| Acera Surgical, INC. | $22.06 | 2025 | Restrata Wound Matrix |
| Atricure, INC. | $22.00 | 2023 | |
| Lemaitre Vascular, INC. | $15.39 | 2022 | |
| Haemonetics Corporation | $14.59 | 2025 | Teg6s Hemostasis System |
| Laborie Medical Technologies Corp. | $14.16 | 2024 | Endosheath Technology |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Creger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.